Jeffrey Aldrich

Jeffrey Aldrich, MD is an Assistant Professor in the Department of Medicine - Oncology at the University of North Carolina at Chapel Hill School of Medicine. He is also a member of the UNC Lineberger Comprehensive Cancer Center and serves as a medical oncologist specializing in breast cancer.

Dr. Aldrich's primary clinical focus is on caring for patients with breast cancer. His research interests center on improving cancer treatment-related side effects and reducing the symptom burden from cancer. He is particularly focused on expanding access to clinical trials for his patients, demonstrating his commitment to bringing the latest therapeutic advances to those under his care. His work bridges clinical practice with research aimed at enhancing patient quality of life during cancer treatment.

His publication record shows engagement in both breast cancer research and broader oncology topics, with recent work examining checkpoint blockers in patients with cancer and pre-existing autoimmune conditions, as well as taxane-based therapies for gastrointestinal cancers. This indicates a research profile that spans both his specialty in breast cancer and wider oncological concerns.

As a clinician-researcher at a comprehensive cancer center, Dr. Aldrich contributes to both patient care and advancing the field of medical oncology through his clinical trial work and research on treatment side effects and symptom management.